Annual Interest Coverage Ratio
-330.77
+217.14+39.63%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual interest coverage ratio is -330.77, with the most recent change of +217.14 (+39.63%) on December 1, 2023.
- During the last 3 years, RNAZ annual interest coverage ratio has fallen by -325.83 (-6595.75%).
- RNAZ annual interest coverage ratio is now -11425.09% below its all-time high of -2.87, reached on December 31, 2019.
Performance
RNAZ Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Coverage Ratio
-213.94
+938.57+81.44%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly interest coverage ratio is -213.94, with the most recent change of +938.57 (+81.44%) on September 1, 2024.
- Over the past year, RNAZ quarterly interest coverage ratio has increased by +91.42 (+29.94%).
- RNAZ quarterly interest coverage ratio is now -419.46% below its all-time high of 66.97, reached on June 30, 2021.
Performance
RNAZ Quarterly Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Coverage Ratio Formula
Interest Coverage Ratio = EBIT
Interest Expense
EBIT
Interest Expense
Interest Expense
RNAZ Interest Coverage Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.6% | +29.9% |
| 3 y3 years | -6595.8% | +97.2% |
| 5 y5 years | -10000.0% | -10000.0% |
RNAZ Interest Coverage Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -366.1% | +39.6% | at high | +81.4% |
| 5 y | 5-year | <-9999.0% | +39.6% | -419.5% | +97.2% |
| alltime | all time | <-9999.0% | +39.6% | -419.5% | +97.2% |
TransCode Therapeutics Interest Coverage Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -213.94(-81.4%) |
| Jun 2024 | - | -1152.51(+237.0%) |
| Mar 2024 | - | -341.97(+45.4%) |
| Dec 2023 | -330.77(-39.6%) | -235.27(-23.0%) |
| Sep 2023 | - | -305.36(-45.0%) |
| Jun 2023 | - | -555.62(+55.0%) |
| Mar 2023 | - | -358.47(-95.4%) |
| Dec 2022 | -547.91(+672.1%) | - |
| Dec 2021 | -70.96 | - |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -7764.67(<-9900.0%) |
| Jun 2021 | - | 66.97(-179.8%) |
| Mar 2021 | - | -83.95(+505.3%) |
| Dec 2020 | -4.94(+72.1%) | - |
| Dec 2020 | - | -13.87(+255.6%) |
| Sep 2020 | - | -3.90(+52.3%) |
| Jun 2020 | - | -2.56(+282.1%) |
| Mar 2020 | - | -0.67 |
| Dec 2019 | -2.87 | - |
FAQ
- What is TransCode Therapeutics annual interest coverage ratio?
- What is the all time high annual interest coverage ratio for TransCode Therapeutics?
- What is TransCode Therapeutics annual interest coverage ratio year-on-year change?
- What is TransCode Therapeutics quarterly interest coverage ratio?
- What is the all time high quarterly interest coverage ratio for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly interest coverage ratio year-on-year change?
What is TransCode Therapeutics annual interest coverage ratio?
The current annual interest coverage ratio of RNAZ is -330.77
What is the all time high annual interest coverage ratio for TransCode Therapeutics?
TransCode Therapeutics all-time high annual interest coverage ratio is -2.87
What is TransCode Therapeutics annual interest coverage ratio year-on-year change?
Over the past year, RNAZ annual interest coverage ratio has changed by +217.14 (+39.63%)
What is TransCode Therapeutics quarterly interest coverage ratio?
The current quarterly interest coverage ratio of RNAZ is -213.94
What is the all time high quarterly interest coverage ratio for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly interest coverage ratio is 66.97
What is TransCode Therapeutics quarterly interest coverage ratio year-on-year change?
Over the past year, RNAZ quarterly interest coverage ratio has changed by +91.42 (+29.94%)